Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 08 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.90 Insider Own51.22% Shs Outstand4.13M Perf Week-2.74%
Market Cap8.80M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.01M Perf Month4.41%
Income-8.59M PEG- EPS next Q-0.20 Inst Own43.35% Short Float / Ratio0.90% / 0.31 Perf Quarter-74.88%
Sales0.00M P/S- EPS this Y- Inst Trans-89.74% Short Interest0.02M Perf Half Y-79.36%
Book/sh3.16 P/B0.67 EPS next Y- ROA-6.24% Target Price10.00 Perf Year-78.64%
Cash/sh0.16 P/C13.13 EPS next 5Y- ROE-6.81% 52W Range1.50 - 13.79 Perf YTD-79.06%
Dividend- P/FCF6.24 EPS past 5Y- ROI-27.48% 52W High-84.55% Beta0.57
Dividend %- Quick Ratio0.10 Sales past 5Y0.00% Gross Margin- 52W Low42.00% ATR0.33
Employees2 Current Ratio0.10 Sales Q/Q- Oper. Margin0.00% RSI (14)48.35 Volatility18.15% 14.28%
OptionableNo Debt/Eq0.05 EPS Q/Q-398.62% Profit Margin- Rel Volume1.51 Prev Close2.32
ShortableYes LT Debt/Eq0.00 EarningsNov 14 AMC Payout0.00% Avg Volume58.45K Price2.13
Recom1.50 SMA206.42% SMA50-10.90% SMA200-72.68% Volume88,240 Change-8.19%
Date Action Analyst Rating Change Price Target Change
Nov-22-23Initiated H.C. Wainwright Buy $11
Oct-09-23Initiated Robert W. Baird Outperform $9
Nov-20-23 07:00AM
Nov-14-23 04:05PM
Nov-03-23 07:00AM
Nov-01-23 07:00AM
Oct-30-23 07:00AM
07:00AM Loading…
Oct-10-23 07:00AM
Sep-13-23 05:50AM
Sep-11-23 04:05PM
Aug-24-23 12:06PM
Aug-22-23 11:41AM
Aug-16-23 06:00AM
Aug-07-23 05:00AM
Jun-23-23 05:00AM
Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company is headquartered in San Diego, CA.